chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizzy; Headache; Blood pressure and found that it was elevated; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), DIZZINESS (Dizzy) and BLOOD PRESSURE INCREASED (Blood pressure and found that it was elevated) in a 53-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE on 10-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE on 31-Mar-2021 and PFIZER BIONTECH COVID-19 VACCINE on 14-Dec-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 02-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), DIZZINESS (Dizzy) and BLOOD PRESSURE INCREASED (Blood pressure and found that it was elevated). At the time of the report, HEADACHE (Headache) and DIZZINESS (Dizzy) had not resolved and BLOOD PRESSURE INCREASED (Blood pressure and found that it was elevated) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure increased: blood pressure and found that it was elevated (130/90).     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was reported. The reporter stated that they had the Moderna bivalent booster dose and had a slight headache after until the next day. But today 08Feb2023, she again had headache which did not seem to subside and she became dizzy for a long period of time. The school nurse where she works took her blood pressure and found that it was elevated (130/90). No treatment medication information was reported.
Information has been received from a physician concerning a 13 year old female patient with a history of passing out every time she received an injection, who on 23-JAN-2009 was vaccination with the first dose of GARDASIL vaccine. Concomitant suspect therapy included VARIVAX vaccine (Oka/Merck) (duration and dose not reported). Other concomitant therapy included FLUMIST and HAVRIX. It was reported that the patient passed out after receiving GARDASIL vaccine. The patient passed out after receiving GARDASIL vaccine. The patient had recovered on 23-JAN-2009. The patient sought medical attention. No further information is available.
MIGRAINE; STOMACH UPSET; CHILLS; NAUSEA; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced migraine, stomach upset, chills, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from migraine, stomach upset, chills, and nausea. This report was non-serious.
Right arm sore; mild flu like symptoms; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 13May2021 at 09:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of vaccination. On 13May2021 at 13:00, the patient experienced right arm sore and mild flu like symptoms. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events right arm sore and mild flu like symptoms was resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Everyone I know who gets the shot gets the flu; Initial information received on 30-Oct-2021 regarding an unsolicited valid social media non-serious case received from a consumer or non-healthcare professional via Regulatory Authority.  This case involves adult patient (unknown demographic) who had gets the shot gets the flu (influenza) after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer [lot number and expiry date not reported] via unknown route in unknown administration site for prophylactic vaccination  On an unknown date the patient developed a non-serious everyone gets the shot gets the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if there were lab data/results available.  It was reported "everyone I know who gets the shot gets the flu. I don't get the shot and I don't get the flu. I guess God gave me a pretty good immune system."  It was unknown if the patient experienced any additional symptoms/events.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
11/08/21 presents to local ED "cold like symptoms" "worsening with continued dry cough, fatigue, low appetite and lost 10 lbs in 1 week".  PMH "HTN, Osteoarthritis"
Patient informed staff upon arrival that this was his first COVID-19 vaccine and would like a moderna shot. Patient filled out COVID-19 Vaccine Documentation/Consent Form and stated "I have never received a covid-19 shot." After patient received shot in LD, staff was in system to update patients vaccination record. Patients record shows 1 doses of pfizer on 08/21/2021.  Patient was asked if she had received any COVID-19 vaccine before. Patient stated "No this is my first COVID-19 shot." Patient denied multiple times of receiving any covid-19 vaccine. Staff verified all the contact information in system and was correct with the patient information. Patient states "President supporters put that into our records we have never had a shot before." Patient waited the 15 minutes without any adverse events.
generalized morbiliform rash w/in 12hr p/vax resolving 72hr;perioribital edema 12hr p/vax resolved by 24hr;no rx given;
This spontaneous report received from a healthcare professional concerned a 54-year-old female. No medical history, weight, height, concomitant medications or concurrent conditions reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch/lot# 212A21A and expiry: May 20, 2022), dose not reported, administered Nov 18, 2021, for immunization. Age at time of vaccination: 54 years old.  On Nov 18, 2021, refrozen vaccine administered to patient. On an unspecified date, patient experienced vaccine refrozen. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome of the refrozen vaccine administered to patient and vaccine refrozen: not reported. This case, from the same reporter linked to 20220538379, 20220537688, 20220537683, 20220538480, 20220538149, 20220537341, 20220537444, 20220538292, 20220537548, 20220537356, 20220538411, 20220537356, 20220537532, 20220537532, 20220538428, 20220538425, 20220538210, 20220538238, 20220538573, 20220538666, 20220538693, 20220538146, 20220538297, 20220538758, 20220537507 and 20220539045.
This was my third miscarriage. However the prior two the child did not grow past 6 weeks. This pregnancy was in its second trimester and had been going perfectly when I got the vaccine. After the vaccine I had horrible headaches and abdominal cramping for days.  I got my COVID booster at 14 weeks 6 days and the baby should've measured at 18 weeks 3 days when we found out we lost him but he only measured at 15w 3d. He had always been measuring on target before then. His due date was going to be 6/24/22.
She got the vaccine and did not get an immediate reaction, and on Thursday morning she was tired and couldn't get out of bed.  So her husband kept her in bed all day and by Friday morning things didn't get any better, and he helped her to get to the end of the bed and went into the kitchen to get breakfast and he heard her fall, and she fell off the bed and was semi-consciousness, and was able to get her back into the bed and called the ambulance.   She was taken to the hospital Friday morning and she's still in there.  She has been diagnosed with hydronephrosis, and they keep going back and forth on her diagnoses.  At first they said that she had a UTI, and then they said she didn't, and then said that she did.  The son feels that all three of the doctors feel that it was some sort of reaction to the vaccine.  They did give her steroids at one time, and she developed severe tremors when she moved which have subsided.  She also has had fever, in a weakened state due to this condition.  She is still being treated for this still and said that she will be having to go to rehabilitation before going home.
Patient states that after receiving these vaccines she became ill around 7 hours later. She described her symptoms as migraine headache, shortness of breath, red injection sites, ringing in the ears, light headedness, trouble walking, joint pain, nausea, and a lack of appetite. Patient states that she took 600 mg of Ibuprofen. She states she considered going the Emergency room but did not. Patient  states she is still pretty wiped out but seems to be getting better.
Diarrhea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and VOMITING (Vomiting) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included Back surgery since an unknown date. Concurrent medical conditions included Wrist injury (Inflammation in wrist). Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced DIARRHOEA (Diarrhea) and VOMITING (Vomiting). At the time of the report, DIARRHOEA (Diarrhea) and VOMITING (Vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Initial report received 27 February 2009 from a health care professional. A 31-year-old female patient had received an intramuscular right deltoid injection of DECAVAC, lot number U2067DA, and a left deltoid injection of Typhim Vi, lot number D0252AA on 23 February 2009 and an unspecified amount of time later, she developed a red and swollen arm (specific arm not reported) and a fever. The patient called her physician on 27 February 2009 to report the symptoms. The patient's recovery status was not provided at the time of the report. The case was a one out of a cluster of two case reports. The reporter for this case is the same as for case number 2009-00818. Documents held by sender: None
This spontaneous report was received from a nurse via a refers to a patient of unknown age (gender unspecified). On an unknown date, the nurse reported that the patient was vaccinated with PNEUMOVAX 23, (lot number, expiration date and route not reported) within a month of each other. No concomitant medications were reported. The pharmacist reported that an unspecified nurse informed her that an unspecified patient was inadvertently administered 2 doses of PNEUMOVAX within a month of each other on unspecified dates and no adverse effects were reported. It was unspecified if the patient had sought medical attention. Additional information is not expected.
This spontaneous report was received from a physician via company representative regarding a female patient of unknown age. Information on concurrent conditions, medical history and drug allergies of the patient were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX (lot, expiry date, route, anatomical location, dose#, dose units were not specified). Concomitant therapies included prednisone (manufacturer unknown). On an unknown date, it was reported that the patient developed shingles after receiving ZOSTAVAX (drug ineffective). The patient had sought medical attention for the adverse events. The outcome of herpes zoster and drug ineffective was unknown at the time of reporting. There was no Product Quality Concerns (PQC) involved. Reporting physician did not provide the causal relationship of the events with ZOSTAVAX. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age and gender. On an unknown date 10 doses of LIQUID PEDVAXHIB (dose, route of administration, LOT# and expiration date were not provided) all of which reached the temperature outside the product information, have been administered to unspecified patients. The temperature was supported. No adverse effects were reported. This is one of several reports from the same source (MARS# 1406USA008283, 1406USA008284, 1406USA007026) Additional information has been requested.
mother was told the shot given in the L thigh was Varicella, has a red circle around the injection site about 2 1/2 inches in diameter
22OCT94 nauseated, severe pain in inject site (lt deltoid), lasted approx 24 hrs; 21OCT94 hx of bronchial asthma, had difficulty w/asthma & needed to use Primetene nasal inhaler x4 p/inject;24OCT94 no redness or soreness in lt arm;
Information has been received from a pharmacist referring to a 61 year old male patient. The patient was allergic to sulfa drugs and he was not immunosuppressed. On 09-JUL-2015 the patient was vaccinated with a dose of ZOSTAVAX (injection, lot # K014835, expiration date as 14-DEC-2015, once, strength and dose were unspecified) subcutaneously in the deltoid muscle of the right arm. No relevant concomitant medications were taken. On an unknown date in July 2015, after receiving the ZOSTAVAX, the patient developed swelling, redness, soreness, tenderness and a hot feeling around the injection site and the injection site reaction was about 1 inch in diameter. Further down the same arm he had swelling, redness and tenderness that was bigger than the injection site reaction. The patient was not seen by his physician so no relevant tests were done. As of 12-JUL-2015, the outcomes of the event were not recovered. Additional information has been requested.
Woke up the morning after my shot with a huge migraine, probably the worst one I've ever had. I was vomiting all day , dripping in sweat, exhausted, and didn't start feeling better until the next afternoon.
No adverse event; Temperature excursion occurred on 29Nov2022. A total of 16 doses were administered on 29Nov2022 (5), 30Nov2022 (4), 1Dec2022 (2), 2Dec2022 (2), 3Dec2022 (1), and 5Dec2022 (2)/ 1 Patient; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29Nov2022. A total of 16 doses were administered on 29Nov2022 (5), 30Nov2022 (4), 1Dec2022 (2), 2Dec2022 (2), 3Dec2022 (1), and 5Dec2022 (2)/ 1 Patient) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Dec-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29Nov2022. A total of 16 doses were administered on 29Nov2022 (5), 30Nov2022 (4), 1Dec2022 (2), 2Dec2022 (2), 3Dec2022 (1), and 5Dec2022 (2)/ 1 Patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29Nov2022. A total of 16 doses were administered on 29Nov2022 (5), 30Nov2022 (4), 1Dec2022 (2), 2Dec2022 (2), 3Dec2022 (1), and 5Dec2022 (2)/ 1 Patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion occurred on 29Nov2022. A total of 16 doses were administered on 29Nov2022 (5), 30Nov2022 (4), 1Dec2022 (2), 2Dec2022 (2), 3Dec2022 (1), and 5Dec2022 (2)/ 1 Patient).    No concomitant medications were reported.  It was reported patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine as unknown.  No treatment medications were reported.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Patient reported a general feeling of numbness associated with extremities (fingertips). Loss of feeling/sensation. No problem moving extremities, but feeling seems to be lacking.
Drowsiness, sleepiness; napping and becoming more drowsy that I typically am; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 76 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Sleep problem" (unspecified if ongoing), notes: Taking diazepam at night to sleep. Concomitant medications included: LISINOPRIL; ALLOPURINOL; PROZAC taken for anxiety; ASPIRIN [ACETYLSALICYLIC ACID]; DIAZEPAM taken for sleep disorder. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN, (Lot number: not provided)), for covid-19 immunization. The following information was reported: SOMNOLENCE (non-serious), outcome "not recovered", described as "Drowsiness, sleepiness; napping and becoming more drowsy that I typically am". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of somnolence.  Additional information: Concomitant medication also included Multivitamins. Consumer stated that he was having some side effects from the second shot that were lingering and he was just wondering to talk to someone about them. Consumer confirmed the vaccine as Pfizer's Covid 19 vaccine. Consumer stated that he had drowsiness and sleepiness. He had his last shot about 4 weeks ago, maybe 5 and he was noticing himself napping and become drowsier than he typically was, and it doesn't seem to have dissipated. He stated that once or twice a week, like tonight he was sitting watching television, he said he needed to stop his eyes and take a nap which he did, and he slept about 3 hours and woke up and still felt sleepy. He received no treatment for the events and all his lab test came normal according to the nurse. He was wondering if this was something that will eventually go away or he knew with the vaccine it was hard to, everyone has a different reaction to it, but he was just checking if there is anything that he could do to make it different because it was 2-3 times a week, with his first shot he had no effect but with the second one he started getting drowsy. He just wanted to talk to someone at Pfizer about it.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
tiny soreness after getting injection; This is a spontaneous report from a contactable consumer(patient) or other non hcp. A 74-years-old female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported), administered in left arm on 16Feb2021 15:00 (at the age of 74-year-old) as DOSE UNK, SINGLE for COVID-19 immunization and paracetamol (TYLENOL) and ibuprofen (MOTRIN) for arthritis. Medical history included arthritis from an unknown date and unknown if ongoing. She is healthy and walks daily. Historical vaccine included Flu shot in Sep2020(She does not have NDC, Lot or Expiry to provide). Concomitant medication included atorvastatin (LIPITOR) taken for blood cholesterol. The patient experienced tiny soreness after getting injection on 16Feb2021. Outcome of the event was recovering.    Follow-up attempts completed. No further information expected.
Fever, Headache, Nausea and Fatigue which resolved within 30 hours after treatment with ibuprofen and rest. Continued soreness and swelling at injection site over 48 hours out from Tdap vaccination.
PATIENT REPORTED A CLEAR LIQUID COMING OUT FROM BANDAID ROUGHLY AN HOUR AFTER VACCINATION
This case was reported by a non-health professional via sales rep and described the occurrence of injection site pain in a male patient who received Shingrix for prophylaxis. Previously administered products included Shingrix with an associated reaction of injection site pain (for tolerance of 1st dose refer case US2018GSK148189). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain was recovered/resolved. It was unknown if the reporter considered the injection site pain to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. After receiving Shingrix, the patient experienced local injection site pain that lasted for 2 days.
Right arm moderate swelling entire arm No lymph nodes in that arm from mastectomy more than 3 years ago No apparent adverse reaction at injection site